
Collection Overview and Research Advantages
Why Researchers Choose This Collection
Built for metabolic disease studies, this collection is designed to help you move from sourcing to experimentation faster, with stronger biological relevance and less guesswork.
Authentic Disease Biology
Source cells from clinically diagnosed diabetic and obese donors instead of relying only on generic healthy controls.
Complete Donor Documentation
Review precise donor information including age, BMI, medications, and disease background to support better study design.
Ready-to-Order Research Solution
Access cells, validated media, differentiation reagents, and optimized protocols in one place for a more streamlined workflow.
The Old Way vs. the abm Advantage
THE OLD WAY
- Source cells from one vendor
- Find compatible media
- Hunt for differentiation reagents
- Troubleshoot compatibility issues
- Spend weeks optimizing protocols
- Wasted time and unpredictable results
THE abm ADVANTAGE
- One complete validated system
- Pre-tested component compatibility
- Optimized protocols included
- Single order, one shipment
- Technical support
- Research-ready workflow with budget certainty
What You Save
Weeks of Sourcing and Optimization Saved
Reduce setup time by avoiding the usual back-and-forth of sourcing cells, media, and reagents separately.
Transparent All-in Pricing Upfront
Plan with more confidence thanks to clear pricing and fewer hidden costs from failed compatibility tests.
Pre-Validated Compatibility
Lower the chance of failed experiments by working with components already validated to perform together.
One Vendor, Technical Expertise
Get help from a single partner who understands the system and can support your research workflow end to end.
abm Collection vs. Typical Competitor
- Age precision: “58 years”
- BMI detail: “26.7 exact”
- Medications: “Simvastatin”
- Paired cells: “Same donor available”
- Age precision: “50–60 years”
- BMI detail: “Overweight”
- Medications: “Not specified”
- Paired cells: “Not offered”
Featured Collection: Type II Diabetes
Explore a sample of fully characterized preadipocyte models with precise donor details for Type II diabetes and related metabolic disease research.
| SKU | Name | Patient Details |
|---|---|---|
| T4328 | Fully Characterized Human Preadipocytes Subcutaneous, Diabetic Adult (HPA-CD) | Female, 58, Caucasian, BMI 26.7, Type 2 Diabetes, Medication (Glucophage, Pariet, Simvastatin, and Coveram) |
| T4335 | Human Preadipocytes Subcutaneous, DB and HT | Female, 69, Caucasian, BMI 24.3, Type 2 Diabetes and Hypertension |
| T4340 | Human Preadipocytes Subcutaneous, Diabetes, HT and HL | Female, 65, Caucasian, BMI 31.2, Diabetes, Hypertension and Hyperlipidemia (Metabolic Syndrome) |
| T4345 | Human Preadipocytes Visceral, Type 2 Diabetes | Male, 58, Caucasian, BMI 43.6, Diabetes Type 2 |
Full Collection Library
Filter the complete DIVA cell collection by category, then click any row to open the matching product page.
| Catalog Number | Product Name | Category |
|---|---|---|
| T4312 | Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-l1) | Subcutaneous Adipose Preadipocytes |
| T4313 | Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-l2) | Subcutaneous Adipose Preadipocytes |
| T4314 | Human Preadipocytes Subcutaneous, Normal Adult (HPA-n1) | Subcutaneous Adipose Preadipocytes |
| T4315 | Human Preadipocytes Subcutaneous, Normal Adult (HPA-n2) | Subcutaneous Adipose Preadipocytes |
| T4316 | Human Preadipocytes Subcutaneous, Normal Adult (HPA-n3) | Subcutaneous Adipose Preadipocytes |
| T4317 | Human Preadipocytes Subcutaneous, Obese Adult (HPA-o1) | Subcutaneous Adipose Preadipocytes |
| T4318 | Human Preadipocytes Subcutaneous, Obese Adult (HPA-o2) | Subcutaneous Adipose Preadipocytes |
| T4319 | Human Preadipocytes Subcutaneous, Obese Adult (HPA-o3) | Subcutaneous Adipose Preadipocytes |
| T4320 | Fully Characterized Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-Cl1) | Subcutaneous Adipose Preadipocytes |
| T4321 | Fully Characterized Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-Cl2) | Subcutaneous Adipose Preadipocytes |
| T4322 | Fully Characterized Human Preadipocytes Subcutaneous, Normal Adult (HPA-Cn1) | Subcutaneous Adipose Preadipocytes |
| T4323 | Fully Characterized Human Preadipocytes Subcutaneous, Normal Adult (HPA-Cn2) | Subcutaneous Adipose Preadipocytes |
| T4324 | Fully Characterized Human Preadipocytes Subcutaneous, Adult with Verneuil's Disease (HPA-Cn3) | Subcutaneous Adipose Preadipocytes |
| T4325 | Fully Characterized Human Preadipocytes Subcutaneous, Obese Adult (HPA-Co1) | Subcutaneous Adipose Preadipocytes |
| T4326 | Fully Characterized Human Preadipocytes Subcutaneous, Obese Adult (HPA-Co2) | Subcutaneous Adipose Preadipocytes |
| T4327 | Human Preadipocytes Subcutaneous - Facial or Eyelid Skin, Normal Adult (HPA-FE) | Face / Eyelid Skin |
| T4328 | Fully Characterized Human Preadipocytes Subcutaneous, Diabetic Adult (HPA-CD) | Subcutaneous Adipose Preadipocytes |
| T4259 | Human Primary Adipose Preadipocyte Cells (Donor F-73-28.4) | Adipose Preadipocytes |
| T4260 | Human Primary Adipose Preadipocyte Cells (Donor F-69-24.6) | Adipose Preadipocytes |
| T4261 | Human Primary Adipose Preadipocyte Cells (Donor M-75-22.3) | Adipose Preadipocytes |
| T4262 | Human Primary Adipose Preadipocyte Cells (Donor F-22-22.2) | Adipose Preadipocytes |
| T4263 | Human Primary Adipose Preadipocyte Cells (Donor M-24-28.7) | Adipose Preadipocytes |
| T4264 | Human Primary Adipose Preadipocyte Cells (Donor F-24-24.8) | Adipose Preadipocytes |
| T4265 | Human Primary Adipose Preadipocyte Cells (Donor F-24-27) | Adipose Preadipocytes |
| T4266 | Human Primary Adipose Preadipocyte Cells (Donor F-66-27) | Adipose Preadipocytes |
| T4267 | Human Primary Adipose Preadipocyte Cells (Donor F-66-28.6) | Adipose Preadipocytes |
| T4268 | Human Primary Adipose Preadipocyte Cells (Donor F-21-32.2) | Adipose Preadipocytes |
| T4269 | Human Primary Adipose Preadipocyte Cells (Donor F-29-29.2) | Adipose Preadipocytes |
| T4329 | Human Preadipocytes Subcutaneous, Hidradenitis Suppurativa | Subcutaneous Adipose Preadipocytes |
| T4330 | Human Preadipocytes Subcutaneous, Latex Allergy | Subcutaneous Adipose Preadipocytes |
| T4331 | Human Preadipocytes Subcutaneous, Asthma and GERD | Subcutaneous Adipose Preadipocytes |
| T4332 | Human Preadipocytes Subcutaneous, Bipolar | Subcutaneous Adipose Preadipocytes |
| T4333 | Human Preadipocytes Subcutaneous, Hypothyroidism (HPA 01) | Subcutaneous Adipose Preadipocytes |
| T4334 | Human Preadipocytes Subcutaneous, Depression (HPA 06) | Subcutaneous Adipose Preadipocytes |
| T4335 | Human Preadipocytes Subcutaneous, DB and HT | Subcutaneous Adipose Preadipocytes |
| T4336 | Human Preadipocytes Subcutaneous, Hypothyroidism (HPA 02) | Subcutaneous Adipose Preadipocytes |
| T4337 | Human Preadipocytes Subcutaneous, Ulcer | Subcutaneous Adipose Preadipocytes |
| T4338 | Human Preadipocytes Subcutaneous, Hypothyroidism (HPA 03) | Subcutaneous Adipose Preadipocytes |
| T4339 | Human Preadipocytes Subcutaneous, Depression (HPA 07) | Subcutaneous Adipose Preadipocytes |
| T4340 | Human Preadipocytes Subcutaneous, Diabetes, HT and HL | Subcutaneous Adipose Preadipocytes |
| T4341 | Human Preadipocytes Visceral, Hypothyroidism | Visceral adipose preadipocytes |
| T4342 | Human Preadipocytes Subcutaneous, Hypothyroidism (HPA 04) | Subcutaneous Adipose Preadipocytes |
| T4343 | Human Preadipocytes Subcutaneous, Hypertension | Subcutaneous Adipose Preadipocytes |
| T4344 | Human Preadipocytes Subcutaneous, Hypothyroidism (HPA 05) | Subcutaneous Adipose Preadipocytes |
| T4345 | Human Preadipocytes Visceral, Type 2 Diabetes | Visceral adipose preadipocytes |
| T4301 | Human Dermal Fibroblasts - Young(≤25 years) (HDF-y2) | Aged Dermal Fibroblasts |
| T4302 | Human Dermal Fibroblasts - Normal (26-49 years) (HDF-n1) | Aged Dermal Fibroblasts |
| T4303 | Human Dermal Fibroblasts - Normal (26-49 years) (HDF-n2) | Aged Dermal Fibroblasts |
| T4304 | Human Dermal Fibroblasts - Aged (≥50 years) (HDF-a1) | Aged Dermal Fibroblasts |
| T4305 | Human Dermal Fibroblasts – Aged (≥50 years) (HDF-a2) | Aged Dermal Fibroblasts |
| T4306 | Fully Characterized Human Dermal Fibroblasts -Young (≤25 years) (HDF-Cy) | Aged Dermal Fibroblasts |
| T4307 | Fully Characterized Human Dermal Fibroblasts - Normal (26-49 years) (HDF-Cn1) | Aged Dermal Fibroblasts |
| T4308 | Fully Characterized Human Dermal Fibroblasts - Normal (26-49 years) (HDF-Cn2) | Aged Dermal Fibroblasts |
| T4309 | Fully Characterized Human Dermal Fibroblasts – Aged (≥50 years) (HDF-Ca) | Aged Dermal Fibroblasts |
| T4310 | Human Dermal Fibroblasts - Facial or Eyelid Skin (HDF-FE) | Face / Eyelid Skin |
| T4311 | Fully Characterized Human Dermal Fibroblasts - Facial or Eyelid Skin (HDF-CFE) | Face / Eyelid Skin |
| T4401 | Human Dermal Fibroblasts, Latex Allergy | Diseased Dermal Fibroblasts |
| T4402 | Human Dermal Fibroblasts, Asthma and GERD | Diseased Dermal Fibroblasts |
| T4403 | Human Dermal Fibroblasts, Bipolar (HDF 01) | Diseased Dermal Fibroblasts |
| T4404 | Human Dermal Fibroblasts, Depression (HDF 03) | Diseased Dermal Fibroblasts |
| T4405 | Human Dermal Fibroblasts, Depression (HDF 04) | Diseased Dermal Fibroblasts |
| T4406 | Human Dermal Fibroblasts, Hypothyroidism (HDF 05) | Diseased Dermal Fibroblasts |
| T4407 | Human Dermal Fibroblasts, Hypothyroidism (HDF 06) | Diseased Dermal Fibroblasts |
| T4408 | Human Dermal Fibroblasts, Hypertension (HDF 09) | Diseased Dermal Fibroblasts |
| T4409 | Human Dermal Fibroblasts, Bipolar (HDF 02) | Diseased Dermal Fibroblasts |
| T4410 | Human Dermal Fibroblasts, Hidradenitis Suppurativa | Diseased Dermal Fibroblasts |
| T4411 | Human Dermal Fibroblasts, Asthma | Diseased Dermal Fibroblasts |
| T4412 | Human Dermal Fibroblasts, GERD | Diseased Dermal Fibroblasts |
| T4413 | Human Dermal Fibroblasts, Hypertension (HDF 10) | Diseased Dermal Fibroblasts |
| T4415 | Human Dermal Fibroblasts, Hypothyroidism (HDF 08) | Diseased Dermal Fibroblasts |
Recommended Media and Reagents
Complete your workflow with the recommended support materials for culturing and differentiating preadipocytes.
| Product Name | Cat. No. | Unit |
|---|---|---|
| Preadipocyte Medium Kit | TM048 | 1 Kit |
| Adipocyte Differentiation Medium | TM005 | 500 ml |
| Dulbecco's Modified Eagle Medium (DMEM), High Glucose | TM500 | 500 ml |
| USDA Research Grade Origin Fetal Bovine Serum | TM999-100 | 100 ml |
| USDA Research Grade Origin Fetal Bovine Serum | TM999-500 | 500 ml |
| L-Glutamine Solution (200 mM) | G275 | 100 ml |
| Penicillin/Streptomycin Solution | G255 | 100 ml |
The abm Difference
More than a supplier, abm is your research partner — delivering trusted quality, rapid access, and expert support from project start to publication.
Ship-Ready Inventory
Our in-stock collection is prepared for fast fulfilment, helping you reduce downtime and move from planning to benchwork without unnecessary delays.
Scientist-to-Scientist Support
Our PhD-level team works with you directly to help identify the right model, recommend culture conditions, and support more complex study design questions.
Complete Documentation
Each order includes essential documentation such as CoA, passage history, culture guidance, and mycoplasma test reports for streamlined lab integration.
Trusted by Thousands
abm cell lines support work across oncology, pharmacology, and molecular biology, helping researchers generate reliable data backed by trusted materials.